Respiri Limited (RSH.AX)

AUD 0.07

(-4.0%)

Market Cap (In AUD)

95.5 Million

Revenue (In AUD)

456.91 Thousand

Net Income (In AUD)

-7.12 Million

Avg. Volume

470.07 Thousand

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.021-0.1
PE
-
EPS
-
Beta Value
-0.174
ISIN
AU000000RSH4
CUSIP
Q8124J104
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Marjan Mikel B.Sc., M.A.I.C.D.
Employee Count
-
Website
https://respiri.co
Ipo Date
2000-07-13
Details
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.